Atrius is an Irish startup company developing a novel, less invasive access system that facilitates percutaneous Transmitral transcatheter mitral valve replacement. Atrius represents a synergistic portfolio of innovative technologies designed to enable simpler, safer, (minimally invasive mediastinal access procedures, such as) transcatheter mitral valve replacement.
PGDx brings proprietary technology to fight against cancer by unlocking actionable information from the genome. PGDx is committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide.
Somatus is a provider of concierge kidney care created to delay or prevent the progression of chronic kidney disease (CKD) to ESRD. Using cutting-edge software to delay disease progression and managed care coordination the company focuses on improving clinical outcomes and enhancing the patient’s experience.
Ascension Ventures is a strategic healthcare venture fund with thirteen limited partners that are all nonprofit healthcare systems representing 474 acute care hospitals in 46 states and the District of Columbia with approximately $88 billion in combined annual operating revenue.
Leavitt Equity Partners (LEP) is a value-add, health care focused private equity fund. LEP targets growth and lower mid-market opportunities aligned with core beliefs about the future of healthcare.
Leerink Transformation Partners LTP is a growth equity fund 100% focused on innovative healthcare IT and services companies. LTP was launched in partnership with LEERINK the highly regarded equity research, M&A advisory and investment banking firm.
Martis Capital is a growth stage investor that targets growth oriented healthcare companies in the middle-market. Martis funds seek to drive sustainable improvements in clinical outcomes. Compliance and costs.
H.I.G. BioHealth Partners invests in a broad range of healthcare companies developing novel products for significant unmet medical needs, primarily in Therapeutics, Medical Devices and Diagnostics.
Vensana Capital, a venture capital & growth equity investment firm dedicated to partnering with entrepreneurs who seek to transform healthcare with breakthrough innovations in medical technology.